Authors


Cheryl Zigrand

Latest:

Advancing Single-Use Technology Through Collaboration

By working together to harmonize the highly variable steps within the biopharmaceutical manufacturing process, both end users and suppliers are making strides toward the efficiency and integrity of single-use technology.



Mollie Shields-Uehling

Latest:

Adapting to Opportunity

The biopharmaceutical industry must continuously evolve to keep up with changing trends.


Aaron Hammons

Latest:

Bioprocessing Technology Trends of RNA-Based Therapeutics and Vaccines

The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.


Youssef Benchek

Latest:

Bioprocessing Technology Trends of RNA-Based Therapeutics and Vaccines

The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.


Elina Gousseinov

Latest:

Bioprocessing Technology Trends of RNA-Based Therapeutics and Vaccines

The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.


Karim Pirani

Latest:

Bioprocessing Technology Trends of RNA-Based Therapeutics and Vaccines

The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.


Mikhail Kozlov

Latest:

Bioprocessing Technology Trends of RNA-Based Therapeutics and Vaccines

The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.


Ling Bei

Latest:

Bioprocessing Technology Trends of RNA-Based Therapeutics and Vaccines

The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.




Barney Zoro

Latest:

Micro-Scale Bioreactors in Fed-batch Microbial Screening

The author outlines key functional attributes to assess a small-scale model.


Kathleen Krafton

Latest:

Lean Changeover in Biopharmaceutical Facilities: Developing A Risk-Based Approach

A streamlined approach may enhance process efficiency and product quality.


David Deere

Latest:

Regulatory Reform in China: Implications for Global Biopharmaceutical Companies

New drug approval policies promote industry growth and injectable contract manufacturing opportunities in China.


Dona York

Latest:

Generating a Fully Processed Antibody

The authors outline cell-line development and process scale-up for an antibody program in which the antibody requires additional processing by a site-specific enzyme for correct functionality.


David Rabuka

Latest:

Generating a Fully Processed Antibody

The authors outline cell-line development and process scale-up for an antibody program in which the antibody requires additional processing by a site-specific enzyme for correct functionality.


Abhishek Saharia

Latest:

Seeking Accelerated Biosimilar Characterization

The authors describe the qualification of an assay with applications for investigating functional comparability of an originator and biosimilar drug.


Naheed Sayeed-Desta

Latest:

Quality Metrics and CMO Agreement

FDA’s focus on the quality culture and its request for quality metrics may ensure a successful company-CMO relationship.


Ajay Pazhayattil

Latest:

Assessing Manufacturing Process Robustness

A structured assessment process can determine compliance to lifecycle process-validation requirements for biopharmaceuticals.


Delia Lyons

Latest:

Perfusion in the 21st Century

Quality, flexibility, and cost savings are driving use of perfusion technology in biosimilars manufacturing.


Bruce Lehr

Latest:

Perfusion in the 21st Century

Quality, flexibility, and cost savings are driving use of perfusion technology in biosimilars manufacturing.


Roger van den Heuvel

Latest:

Disruptive External Factors Dictate Radical Internal Changes for Pharma

Pharmaceutical companies need to radically change to survive and thrive amid shifting healthcare and technology changes.


Timo Simmen

Latest:

Evaluating Technology and Innovation in Biopharmaceutical Manufacturing

A technology management process identifies and evaluates new technologies in biopharmaceutical manufacturing to aid business decisions.


Stefan Merkle

Latest:

Evaluating Technology and Innovation in Biopharmaceutical Manufacturing

A technology management process identifies and evaluates new technologies in biopharmaceutical manufacturing to aid business decisions.


Ranjit Thakur

Latest:

Evaluating Technology and Innovation in Biopharmaceutical Manufacturing

A technology management process identifies and evaluates new technologies in biopharmaceutical manufacturing to aid business decisions.


Camal Handor

Latest:

Evaluating Technology and Innovation in Biopharmaceutical Manufacturing

A technology management process identifies and evaluates new technologies in biopharmaceutical manufacturing to aid business decisions.


Ramanathan Venkataraman

Latest:

Evaluating Technology and Innovation in Biopharmaceutical Manufacturing

A technology management process identifies and evaluates new technologies in biopharmaceutical manufacturing to aid business decisions.


Tatyana Mezhebovsky

Latest:

Enabling Freeze-Thaw Stability of PBS-Based Formulations of a Monoclonal Antibody Part III: Effect of Glass Transition Temperature

An approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.


Eric Routhier

Latest:

Enabling Freeze-Thaw Stability of PBS-Based Formulations of a Monoclonal Antibody Part III: Effect of Glass Transition Temperature

An approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.


Philip Sass

Latest:

Enabling Freeze-Thaw Stability of PBS-Based Formulations of a Monoclonal Antibody Part III: Effect of Glass Transition Temperature

An approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.

© 2025 MJH Life Sciences

All rights reserved.